Over the past few months, we’ve explored and explained how no-shows and care deferrals have impacted health systems and debated the effectiveness of nudges on moving people to better health. During this event, our own Dr. Amy Bucher, Lirio’s chief behavioral officer, will tie it all together with an examination of the impact of Precision Nudging™ in helping HCOs activate consumers to both drive revenue, close gaps in care, and improve outcomes. Amy co-authored a study with Lirio’s Brenton Powers, MBA on the economic impact model for moving people with diabetes–based on their biometric data–to engage with their primary care physicians, which can play a significant role in reducing A1c levels.
During this event, you’ll learn:
Join us for what promises to be a lively and informative discussion.
About Amy Bucher
Amy literally wrote the book on designing for behavior change. She is in demand as an authoritative voice on behavior change for better health, and is a frequent speaker at healthcare, behavior change, and user experience events where she talks about motivation, engagement, and product design. Amy heads Lirio’s behavioral research and design initiatives, and leads a team of behavioral scientists and designers with diverse backgrounds and interests to deliver solutions that drive better health outcomes.
Managing diabetes and the related co-morbidities requires consistent physician care to monitor key factors like A1C and ensure proper medications are available to the patient. One of the largest health systems in the US partnered with Lirio to co-develop a Precision Nudging™ solution utilizing hyper-personalized patient communications for people with diabetes.
Behavioral interventions targeting vaccine adoption, which we designed for a Louisiana health system, have implications for any behavioral intervention aimed at improving and sustaining health behaviors. I recently had the opportunity to share the lessons we learned at a meeting of the Virginia chapter of HIMSS.